tradingkey.logo
tradingkey.logo
Pesquisar

Oncology Institute Inc

TOI
Adicionar à lista de desejos
4.000USD
+0.020+0.50%
Fechamento 05/18, 16:00ETCotações atrasadas em 15 min
399.90MValor de mercado
PerdaP/L TTM

Mais detalhes de Oncology Institute Inc Empresa

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Informações de Oncology Institute Inc

Código da empresaTOI
Nome da EmpresaOncology Institute Inc
Data de listagemMar 13, 2020
CEOVirnich (Daniel)
Número de funcionários825
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 13
Endereço18000 Studebaker Rd
CidadeCERRITOS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal90703
Telefone15627353226
Sitehttps://theoncologyinstitute.com/
Código da empresaTOI
Data de listagemMar 13, 2020
CEOVirnich (Daniel)

Executivos da empresa Oncology Institute Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
715.98K
-145.44%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
69.05K
-252.61%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
51.29K
-711.93%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
715.98K
-145.44%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
69.05K
-252.61%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
51.29K
-711.93%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Por EmpresaUSD
Nome
Receita
Proporção
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Dispensary revenue
269.18M
53.54%
FFS revenue
148.51M
29.54%
Capitated revenue
80.48M
16.01%
Clinical research trials and other revenue
4.56M
0.91%

Distribuição de ações

Atualizado em: qui, 14 de mai
Atualizado em: qui, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Chernett (Jorey)
10.50%
M33 Growth LLC
5.45%
OncologyCare Partners LLC
4.11%
Parian Global Management LP
3.55%
Vanguard Capital Management, LLC
3.48%
Outro
72.91%
Investidores
Investidores
Proporção
Chernett (Jorey)
10.50%
M33 Growth LLC
5.45%
OncologyCare Partners LLC
4.11%
Parian Global Management LP
3.55%
Vanguard Capital Management, LLC
3.48%
Outro
72.91%
Tipos de investidores
Investidores
Proporção
Investment Advisor
15.57%
Individual Investor
14.00%
Hedge Fund
13.03%
Investment Advisor/Hedge Fund
10.32%
Venture Capital
5.49%
Corporation
4.11%
Research Firm
1.51%
Private Equity
0.25%
Bank and Trust
0.16%
Outro
35.55%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
204
47.47M
47.57%
-10.14M
2025Q4
172
39.89M
40.55%
-15.45M
2025Q3
145
39.72M
42.48%
-7.79M
2025Q2
119
39.72M
44.51%
-19.63M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Chernett (Jorey)
10.48M
10.6%
+5.36M
+104.88%
Mar 27, 2026
M33 Growth LLC
5.44M
5.51%
-3.08M
-36.13%
Nov 18, 2025
OncologyCare Partners LLC
4.11M
4.16%
--
--
Mar 26, 2025
BlackRock Institutional Trust Company, N.A.
3.48M
3.52%
+358.84K
+11.51%
Dec 31, 2025
Deerfield Management Company, L.P.
3.36M
3.4%
--
--
Dec 31, 2025
Kanen Wealth Management, LLC
2.98M
3.01%
+1.13M
+61.56%
Dec 31, 2025
Balyasny Asset Management LP
2.52M
2.55%
+100.00
+0.00%
Dec 31, 2025
Josh Arnold Investment Consultant, LLC
2.46M
2.49%
+2.26M
+1104.31%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Vanguard US Momentum Factor ETF
0.11%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Vanguard US Momentum Factor ETF
Proporção0.11%
iShares Micro-Cap ETF
Proporção0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.03%
Global X Russell 2000 ETF
Proporção0.01%
ProShares Hedge Replication ETF
Proporção0.01%
iShares Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.01%
iShares Russell 2000 Growth ETF
Proporção0.01%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI